Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
Xiwei Yu,1,* Guang Yang,2,* Yijie Shi,1 Chang Su,3 Ming Liu,1 Bo Feng,1 Liang Zhao1 1School of Pharmacy, Liaoning Medical University, Jinzhou, People’s Republic of China; 2Department of Oncology, BenQ Medical Center, Nanjing Medical University, Nanjing, People’s Republic of Chin...
Guardado en:
Autores principales: | Yu XW, Yang G, Shi YJ, Su C, Liu M, Feng B, Zhao L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0b94ca4acc64a8f90f8c73593f00820 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
por: Zhang DD, et al.
Publicado: (2017) -
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells
por: Bao-an Chen, et al.
Publicado: (2010) -
Targeted multidrug delivery system to overcome chemoresistance in breast cancer
por: Tang Y, et al.
Publicado: (2017) -
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra M, et al.
Publicado: (2013) -
A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours
por: Regino Mercado-Lubo, et al.
Publicado: (2016)